19 June 2013
Keywords: barrier, 1st-qtr, loss, narrows, usa-based, therapeutics, first-quarter
Article | 12 May 2008
USA-based Barrier Therapeutics' first-quarter 2008 revenues totaled $8.4 million, up 207% year-on-year, as net loss narrowed 9% to $14.0 million, or $0.40 per share. The deficit ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.